HAL
50
3
CMCSA
55
2
MCHP
47
2
MCK
64
-2
XEL
39
-30
MSI
43
6
THC
45
-17
SRE
40
-28
EFX
50
-2
CCI
36
3
ROP
42
-23
TRIP
52
-29
ETN
55
-6
AMG
71
-3
HPE
63
-3
AIZ
76
13
RCL
62
-18
KMX
40
-7
FOX
62
2
TDC
63
-15
HAL
50
3
CMCSA
55
2
MCHP
47
2
MCK
64
-2
XEL
39
-30
MSI
43
6
THC
45
-17
SRE
40
-28
EFX
50
-2
CCI
36
3
ROP
42
-23
TRIP
52
-29
ETN
55
-6
AMG
71
-3
HPE
63
-3
AIZ
76
13
RCL
62
-18
KMX
40
-7
FOX
62
2
TDC
63
-15
Financhill
Back

Ares Dynamic Credit Allocation Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
32

ARDC
Ares Dynamic Credit Allocation Fund

Last Price:
$13.32
Seasonality Move:
2.32%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.51
Seasonality Move:
-18.07%
Sell
32
Ares Dynamic Credit Allocation Fund (ARDC) is a Sell

Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?

  • The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $13.34. The Score for ARDC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARDC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARDC Stock Price Chart

What is Ares Dynamic Credit Allocation Fund's stock price today?

  • The Ares Dynamic Credit Allocation Fund share price today is $13.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing slight selling pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

ARDC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.59 Sell
Chaikin Money Flow: -50521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.33 - 13.71) Sell
Bollinger Bands (100): (13.5 - 14.54) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: -20975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.65) Sell
Bollinger Bands (100): (12.3 - 15.28) Sell

ARDC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.37 Sell
20-day SMA: 13.44 Sell
50-day SMA: 13.57 Sell
200-day SMA: 14 Sell
8-day EMA: 13.38 Sell
20-day EMA: 13.46 Sell
50-day EMA: 13.64 Sell
200-day EMA: 14.07 Sell

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.32 Sell
20-day SMA: 11.56 Buy
50-day SMA: 12.92 Sell
200-day SMA: 11.86 Sell
8-day EMA: 12.05 Sell
20-day EMA: 12.05 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.23 Sell

Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Ares Dynamic Credit Allocation Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):